Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00236015

Public ClinicalTrials.gov record NCT00236015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Gabitril at 4, 8, and 12 mg/Day in the Treatment of Adults With Generalized Anxiety Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).

Study identification

NCT ID
NCT00236015
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
880 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2004 (Type not available)
Primary completion
Not listed
Completion
Mar 2006 (Type not available)
Last update posted
May 9, 2014

2004 – 2006

United States locations

U.S. sites
48
U.S. states
27
U.S. cities
46
Facility City State ZIP Site status
Pivotol Research Centers Mesa Arizona 85210 —
Pivotal Research Center Peoria Arizona 85381 —
Valley Clinical Research El Centro California 92243 —
Radiant Research Irvine Irvine California 92618 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pharmacology Research Institute Riverside California 92506 —
Clinical Innovations, Inc. Santa Ana California 92705 —
Radiant Research Denver Colorado 80212 —
University of Connecticut Health Center Farmington Connecticut 06030-6415 —
Miami Research Associates Miami Florida 33173 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806 —
Roskamp Institute, Clinical Trials Division Sarasota Florida 34243 —
Stedman Clinical Trials Tampa Florida 33613 —
Emory University Atlanta Georgia 30329 —
American Medical Research Aurora Illinois 60506 —
Henry Lahmeyer MD & Associates Northfield Illinois 60093 —
Midwest Center for Neurobehavioral Medicine Oakbrook Terrace Illinois 60181 —
Indiana University Hospital AOC Indianapolis Indiana 46202 —
Vince & Associates Clinical Research Overland Park Kansas 66211 —
Pedia Research, LLC Owensboro Kentucky 42301 —
Four Rivers Clinical Research Paducah Kentucky 42003 —
LSU Health Science Center Shreveport Louisiana 71103 —
Capital Clinical Research Associates Rockville Maryland 20852 —
Dupont Clinical Research Rockville Maryland 20852 —
Center for Psychopharmacologic Research and Treatment Worcester Massachusetts 01605 —
Wayne State University Detroit Michigan 48207 —
Regions Hospital - Department of Behavioral Health Saint Paul Minnesota 55101 —
Radiant Research Las Vegas Nevada 89146 —
Center for Emotional Fitness Moorestown New Jersey 08057 —
Fieve Clinical Services, Inc. New York New York 10021 —
Behavioral Medical Research of Staten Island Staten Island New York 10305 —
Medark Clinical Trials and Research Morganton North Carolina 28655 —
Richard Weisler, MD and Associates Raleigh North Carolina 27609 —
Wake Research Associates, LLC Raleigh North Carolina 27612 —
Midwest Clinical Research Center Dayton Ohio 45408 —
Pahl Pharmaceutical Research, LLC Oklahoma City Oklahoma 73118 —
Oregon Center for Clinical Investigations, Inc. Eugene Oregon 97401 —
Keystone Clinical Studies, LLC Norristown Pennsylvania 19401 —
CNS Research Institute Philadelphia Pennsylvania 19149 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Future Search Trials Austin Texas 78756 —
Claghorn-Lesem Research Clinic, Inc. Bellaire Texas 77401 —
Mood Disorders Research Clinic; UT Southwestern Medical Center at Dallas Dallas Texas 75235 —
R/D Clinical Research, Inc. Lake Jackson Texas 77566 —
Croft Group Research Center San Antonio Texas 78229 —
University of Utah Mood Disorders Clinic Salt Lake City Utah 84132 —
Dean Foundation Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00236015 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →